pepinemabin

Vaccinex’s Phase Ib/II trial for Alzheimer’s treatment hits primary endpoint
Clinical Trials Arena
Wed, 07/31/24 - 11:14 pm
Vaccinex
clinical trials
Alzheimer's disease
pepinemabin